Yan Zhen1,2, Hélène Spangenberg1,2, Michael J. Munson1,3, Andreas Brech1,2, Kay Oliver Schink1,2, Kia Wee Tan1,2, Vigdis Sørensen1,2, Eva M. Wenzel1,2, Maja Radulovic1,2, Nikolai Engedal4, Anne Simonsen1,3, Camilla Raiborg1,2, Harald Stenmark1,2
1Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway
2Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norway
3Department of Molecular Medicine, Institute of Basic Medical Sciences, Oslo, Norway
4Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway